• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

TGen launches Vidium Animal Health

October 12, 2020
dvm360 Staff
dvm360, dvm360 October 2020, Volume 51, Issue 10

Genomic based-precision medicine from the TGen subsidiary provides additional resources to assist both veterinary oncologists and pet owners in the diagnostics and treatment of canine cancer.

Translational Genomics Research Institute (TGen), an affiliate of California-based cancer research and treatment center City of Hope, has announced the launch of Vidium Animal Health, which provides genomic-based precision medicine to both veterinary oncologists and pet owners.

“Vidium is built around the human-animal bond,” says President David Haworth, DVM, PhD. “When a pet is diagnosed with cancer, it can be a really scary time for everyone, so we want to offer the very best information, and hope, that science can offer.”

The company offers SearchLight DNA, “a test designed specifically to identify any of the nearly 120 known cancer-associated genetic mutations in dogs, and use the molecular profile of misbehaving genes to help guide diagnosis and treatment,” according to a company press release.

“Vidium was born from our finding that the genetic underpinnings of canine cancers reflected the same fundamental science that allowed us to apply precision medicine toward treating human cancers,” says Will Hendricks, PhD, an assistant professor in TGen's Integrated Cancer Genomics Division who has worked for years in the comparative oncology space.

“It’s clearly a two-way street, with both humans and dogs benefiting from the exchange,” Hendricks says. “Cancer gene mutations that have clinical importance in canine oncology are abundant, and with SearchLight DNA, our goal is to equip veterinarians with the best information possible to help guide the clinical management of the dogs in their care.”

Advertisement

SearchLight DNA reports aim to strengthen the communication gap between veterinarians and pet parents, with scientific language in the clinician’s report paired with lay language for pet owners.

Katie Banovich, Vidium's director of operations, said the absence of genomic technology in the care of pets is a tremendous void that Vidium hopes to fill, but only with the participation of veterinarians and pet parents.

“Through application of multi-disciplinary genomic science, we want to position Vidium as a partner in the veterinary care team,” Banovich says. “We want to be a guide. We want to work with veterinarians.”

download issueDownload Issue: dvm360 October 2020

Related Content:

OncologyOne HealthMedicaldvm360 October 2020
3 Must-reads for National Poison Prevention Week
3 Must-reads for National Poison Prevention Week
UC Davis study on eye diseases in kittens
UC Davis study on eye diseases in kittens
Dr Natalie Marks to lecture on diabetes management with Dr Adam Christman
Dr Natalie Marks to lecture on diabetes management with Dr Adam Christman

Advertisement

Latest News

Xylazine moves from the stables to the streets

DEA reports widespread threat of fentanyl mixed with xylazine

3 Must-reads for National Poison Prevention Week

UC Davis study on eye diseases in kittens

View More Latest News
Advertisement